SCHEMBL3418230

SCHEMBL3418230

COc1c(Cl)c(C(=O)O)c(OC)c2c1C(=O)OC21c2ccc(O)cc2Oc2c1ccc(O)c2Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.45
ALDH1A1 P00352 3/20 0.45
BRCA1 P38398 2/20 0.45
HSD17B10 Q99714 2/20 0.45
CYP2C9 P11712 1/20 0.45
ALOX15 P16050 1/20 0.45
ALOX12 P18054 1/20 0.45
SMAD3 P84022 2/20 0.41
FTO Q9C0B1 7/20 0.37
RECQL P46063 3/20 0.37
TDP1 Q9NUW8 3/20 0.37
MEN1 O00255 2/20 0.37
BLM P54132 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
PRMT1 Q99873 1/20 0.37
ACE2 Q9BYF1 1/20 0.37
THRB P10828 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3699713 0.79 ALDH1A1 (0.45) HPGDALDH1A1BRCA1HSD17B10CYP2C9
SCHEMBL1463748 0.79 SMAD3 (0.65) HPGDALDH1A1BRCA1HSD17B10CYP2C9
SCHEMBL9074904 0.77 ALDH1A1 (0.45) HPGDALDH1A1BRCA1HSD17B10CYP2C9
SCHEMBL15648378 0.77 ALDH1A1 (0.55) HPGDALDH1A1BRCA1HSD17B10CYP2C9
SCHEMBL9017210 0.77 ALDH1A1 (0.55) HPGDALDH1A1BRCA1HSD17B10CYP2C9
SCHEMBL6251430 0.76 FTO (0.39) HPGDALDH1A1BRCA1HSD17B10CYP2C9
SCHEMBL5968975 0.76 FTO (0.50) HPGDALDH1A1BRCA1HSD17B10CYP2C9
SCHEMBL17001191 0.75 SMAD3 (0.45) HPGDALDH1A1BRCA1HSD17B10ALOX15
SCHEMBL6884426 0.74 ALDH1A1 (0.45) HPGDALDH1A1BRCA1HSD17B10CYP2C9
SCHEMBL5148271 0.73 ALDH1A1 (0.59) HPGDALDH1A1BRCA1HSD17B10CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4340866-A1 IL-21 POLYPEPTIDES AND TARGETED CONSTRUCTS Asher Biotherapeutics, Inc. (US) 2024-03-27 EP disclosed
WO-2023164591-A2 SYSTEMS AND METHODS FOR TRANSPOSING CARGO NUCLEOTIDE SEQUENCES METAGENOMI, INC. (US) 2023-08-31 WO disclosed
WO-2023102550-A2 COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY THE BROAD INSTITUTE, INC. (US) 2023-06-08 WO disclosed
EP-3574101-B1 REPAIR TEMPLATE LINKAGE TO ENDONUCLEASES FOR GENOME ENGINEERING KWS SAAT SE & CO KGAA (DE) 2023-04-19 EP disclosed
US-20210230616-A1 METHODS FOR ISOLATING CELLS WITHOUT THE USE OF TRANSGENIC MARKER SEQUENCES INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES (CN) 2021-07-29 US disclosed
US-20210071189-A1 CPF1 BASED TRANSCRIPTION REGULATION SYSTEMS IN PLANTS KWS SAAT SE & Co. KGaA (DE) 2021-03-11 US disclosed
EP-3728605-A2 CPF1 BASED TRANSCRIPTION REGULATION SYSTEMS IN PLANTS KWS SAAT SE & Co. KGaA (DE) 2020-10-28 EP disclosed
EP-3728604-A2 TARGETED TRANSCRIPTIONAL REGULATION USING SYNTHETIC TRANSCRIPTION FACTORS KWS SAAT SE & Co. KGaA (DE) 2020-10-28 EP disclosed
US-20200332307-A1 TARGETED TRANSCRIPTIONAL REGULATION USING SYNTHETIC TRANSCRIPTION FACTORS KWS SAAT SE & Co. KGaA (DE) 2020-10-22 US disclosed
EP-3635118-A1 METHODS FOR ISOLATING CELLS WITHOUT THE USE OF TRANSGENIC MARKER SEQUENCES Institute Of Genetics And Developmental Biology Chinese Academy of Sciences (CN) 2020-04-15 EP disclosed
US-20190161760-A1 HYBRID NUCLEIC ACID SEQUENCES FOR GENOME ENGINEERING KWS SAAT SE (DE) 2019-05-30 US disclosed
EP-3464594-A1 HYBRID NUCLEIC ACID SEQUENCES FOR GENOME ENGINEERING KWS SAAT SE (DE) 2019-04-10 EP disclosed
WO-2018202199-A1 METHODS FOR ISOLATING CELLS WITHOUT THE USE OF TRANSGENIC MARKER SEQUENCES INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY, CHINESE ACADEMY OF SCIENCES (CN) 2018-11-08 WO disclosed
WO-2018138385-A1 REPAIR TEMPLATE LINKAGE TO ENDONUCLEASES FOR GENOME ENGINEERING KWS SAAT SE (DE) 2018-08-02 WO disclosed
WO-2017207589-A1 HYBRID NUCLEIC ACID SEQUENCES FOR GENOME ENGINEERING KWS SAAT SE (DE) 2017-12-07 WO disclosed
EP-2175999-A1 INSTRUMENT AND RECEPTACLES FOR USE IN PERFORMING PROCESSES Gen-Probe Incorporated (US) 2010-04-21 EP disclosed
WO-2009002447-A1 INSTRUMENT AND RECEPTACLES FOR USE IN PERFORMING PROCESSES GEN-PROBE INCORPORATED (US) 2008-12-31 WO disclosed
WO-2004068136-A1 IMPROVED ANOVA METHOD FOR DATA ANALYSIS ROSETTA INPHARMATICS LLC (US) 2004-08-12 WO disclosed
EP-1154990-A1 PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-11-21 EP disclosed
WO-2000048990-A1 PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-08-24 WO disclosed